89 related articles for article (PubMed ID: 15193973)
1. Laboratory variables and stratification of metastatic colorectal cancer patients: recommendations for therapeutic trials and for clinical practice guidelines.
Watine J; Friedberg B
Clin Chim Acta; 2004 Jul; 345(1-2):1-15. PubMed ID: 15193973
[TBL] [Abstract][Full Text] [Related]
2. [Laboratory variables and stratification of small-cell lung cancer patients: recommendations for therapeutic trials and for clinical practice guidelines].
Watine J; Friedberg B; Charet JC
Ann Biol Clin (Paris); 2004; 62(2):189-96. PubMed ID: 15047471
[TBL] [Abstract][Full Text] [Related]
3. [Unresected colorectal liver metastases: prognostic value of laboratory variables].
Friedberg B; Watine J; Miédougé M
Gastroenterol Clin Biol; 2001 Nov; 25(11):962-6. PubMed ID: 11845046
[TBL] [Abstract][Full Text] [Related]
4. [Biological variables and stratification of patients with inoperable non-small-cell bronchial cancer: recommendations for future trials].
Watine J; Friedberg B; Bouarioua N
Cancer Radiother; 2002 Jun; 6(4):209-16. PubMed ID: 12224487
[TBL] [Abstract][Full Text] [Related]
5. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
6. Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.
He WZ; Guo GF; Yin CX; Jiang C; Wang F; Qiu HJ; Chen XX; Rong RM; Zhang B; Xia LP
Colorectal Dis; 2013 Aug; 15(8):e443-52. PubMed ID: 23621885
[TBL] [Abstract][Full Text] [Related]
7. Are laboratory investigations recommended in current medical practice guidelines supported by available evidence?
Watine J
Clin Chem Lab Med; 2002 Mar; 40(3):252-5. PubMed ID: 12005215
[TBL] [Abstract][Full Text] [Related]
8. Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: a proposal for standardization of patient characteristic reporting and stratification.
Sorbye H; Köhne CH; Sargent DJ; Glimelius B
Ann Oncol; 2007 Oct; 18(10):1666-72. PubMed ID: 17660495
[TBL] [Abstract][Full Text] [Related]
9. Prognostic variable in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy.
Fountzilas G; Gossios K; Zisiadis A; Svarna E; Skarlos D; Pavlidis N
Med Pediatr Oncol; 1996 May; 26(5):305-17. PubMed ID: 8614363
[TBL] [Abstract][Full Text] [Related]
10. Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: A systematic review.
Goey KKH; Mahmoud R; Sørbye H; Glimelius B; Köhne CH; Sargent DJ; Punt CJA; van Oijen MGH; Koopman M
Eur J Cancer; 2018 Jun; 96():115-124. PubMed ID: 29729562
[TBL] [Abstract][Full Text] [Related]
11. CA19-9 as the most significant prognostic indicator of metastatic colorectal cancer.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Hepatogastroenterology; 2002; 49(43):160-4. PubMed ID: 11941943
[TBL] [Abstract][Full Text] [Related]
12. [Standards, options and recommendations for tumor markers in colorectal cancer].
Eche N; Pichon MF; Quillien V; Gory-Delabaere G; Riedinger JM; Basuyau JP; Daver A; Buecher B; Conroy T; Dieu L; Bidart JM; Deneux L;
Bull Cancer; 2001 Dec; 88(12):1177-206. PubMed ID: 11792611
[TBL] [Abstract][Full Text] [Related]
13. [Systematic review of the methodology quality and reporting quality in colorectal cancer screening guidelines].
Li J; Yao PT; Niu JQ; Sun X; Ren JS; Chen HD; Li X; Wei LP; Lyu ZY; Feng XS; Chen WQ; Li N; Dai M
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Apr; 53(4):398-404. PubMed ID: 30982275
[No Abstract] [Full Text] [Related]
14. [Clinical practice guideline: 2003 update of Standards, Options et Recommendations for first line palliative chemotherapy in patients with metastatic colorectal cancer (summary report)].
Conroy T; Gory-Delabaere G; Adenis A; Bosquet L; Bouché O; Louvet C; Mitry E; Bécouarn Y; Bosset JF; Ducreux M; Etienne PL; Merrouche Y; Monges G; Rougier P; ; ; ; ; ; ; ;
Bull Cancer; 2004 Oct; 91(10):759-68. PubMed ID: 15556876
[TBL] [Abstract][Full Text] [Related]
15. Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer. Adopted on May 17, 1996 by the American Society of Clinical Oncology.
J Clin Oncol; 1996 Oct; 14(10):2843-77. PubMed ID: 8874347
[TBL] [Abstract][Full Text] [Related]
16. Systematic survey of therapeutic trials for metastatic colorectal cancer: room for improvement in the critical pathway.
Kopetz S; Overman M; Chang DZ; Glover KY; Shureiqi I; Wolff RA; Abbruzzese JL; Eng C
J Clin Oncol; 2008 Apr; 26(12):2000-5. PubMed ID: 18421052
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groups.
Freyer G; Rougier P; Bugat R; Droz JP; Marty M; Bleiberg H; Mignard D; Awad L; Herait P; Culine S; Trillet-Lenoir V
Br J Cancer; 2000 Aug; 83(4):431-7. PubMed ID: 10945486
[TBL] [Abstract][Full Text] [Related]
18. [Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].
Haie-Meder C; Fervers B; Chauvergne J; Fondrinier E; Lhommé C; Guastalla JP; Resbeut M
Bull Cancer; 1999 Oct; 86(10):829-41. PubMed ID: 10572234
[TBL] [Abstract][Full Text] [Related]
19. Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
Oestreicher P
ONS Connect; 2007; 22(8 Suppl):37-8. PubMed ID: 17824557
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
